盤龍藥業(002864.SZ):捐贈100萬元物資及現金支持抗擊新冠疫情
格隆匯2月6日丨盤龍藥業(002864.SZ)公佈,當前,新型冠狀病毒肺炎疫情防控形勢嚴峻,疫情防控工作正處於關鍵時期。公司作為國內醫藥上市公司,高度關注疫情發展,積極響應黨和政府的號召,積極投身疫情防控工作,切實履行上市公司社會責任。公司於2020年2月6日向陝西省紅十字會捐贈價值90餘萬元的藥品及醫療物資和人民幣10萬元用於援疫情防疫工作,捐獻物資包括清熱解毒片、板藍根顆粒、精製銀翹解毒片、三黃片、黃柏膠囊、柴黃片及84消毒液等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.